etoposide has been researched along with Carcinoid Tumor in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.00) | 18.7374 |
1990's | 5 (25.00) | 18.2507 |
2000's | 7 (35.00) | 29.6817 |
2010's | 5 (25.00) | 24.3611 |
2020's | 2 (10.00) | 2.80 |
Authors | Studies |
---|---|
Asanuma, K; Fujishima, F; Furukawa, T; Hata, T; Hatta, W; Koike, T; Masamune, A; Saito, M; Unno, M | 1 |
Halfdanarson, TR; Leventakos, K; Molina, JR; Uprety, D | 1 |
Chi, YH; Du, F; Jiang, WC; Song, Y; Sun, YK; Wang, JW; Yang, L; Zhou, AP | 1 |
Boikos, SA; Brahmer, JR; Ettinger, DS; Forde, PM; Giaccone, G; Hann, CL; Hooker, CM; Illei, PB; Kelly, RJ; Petrini, I; Rudin, CM; Yang, SC | 1 |
Baudin, E; Caplin, ME; Ferolla, P; Filosso, P; Garcia-Yuste, M; Lim, E; Oberg, K; Pelosi, G; Perren, A; Rossi, RE; Travis, WD | 1 |
Wolin, EM | 1 |
Amano, H; Jujoh, T; Kasahara, Y; Kuroda, F; Kurosu, K; Sakao, S; Tada, Y; Takiguchi, Y; Tanabe, N; Tatsumi, K; Yamada, T | 1 |
Hatao, K; Takahashi, T; Tanizawa, Y; Yamashita, Y | 1 |
Kondo, T; Murase, K; Ozeki, Y; Shimamoto, T; Sugimoto, T | 1 |
Baishnab, E; Caplin, ME; Standish, RA; Toumpanakis, C; Winslet, MC | 1 |
Balta, Z; Büttner, R; Fischer, HP; Hirner, A; Sauerbruch, T | 1 |
Kvols, LK | 1 |
Buettner, H; Fan, JT; Ortiz, RG | 1 |
Chico, A; Ciprés, L; Matías-Guiu, X; Pallarés, MC; Puig-Domingo, M; Webb, SM | 1 |
Etoh, Y; Imamura, H; Kamio, T; Nogami, T; Nomura, H; Saeki, T; Sakai, K; Suko, H; Suko, S; Tokunaga, H | 1 |
Haque, AK; Mathew, P; Roberts, JA; Zwischenberger, J | 1 |
Anthony, LB; Drouant, G; Espanan, GD; Maloney, TJ; McCarthy, KE; Meyers, MO; Woltering, EA | 1 |
Eriksson, B; Fjällskog, ML; Granberg, D; Grimfjärd, P; Oberg, K; Skogseid, B; Wilander, E | 1 |
Kvols, LK; Moertel, CG; O'Connell, MJ; Rubin, J | 1 |
Cheng, E; Fiore, J; Heelan, R; Kelsen, D; Magill, G | 1 |
4 review(s) available for etoposide and Carcinoid Tumor
Article | Year |
---|---|
Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Capecitabine; Carcinoid Tumor; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Everolimus; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Lymph Node Excision; Molecular Targeted Therapy; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pneumonectomy; Protein Kinase Inhibitors; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Temozolomide; Watchful Waiting | 2020 |
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchoscopy; Carboplatin; Carcinoid Heart Disease; Carcinoid Tumor; Cisplatin; Dacarbazine; Etoposide; Europe; Humans; Lung Neoplasms; Pneumonectomy; Positron-Emission Tomography; Receptors, Somatostatin; Societies, Medical; Temozolomide; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma, Neuroendocrine; Cisplatin; Disease Management; Etoposide; Everolimus; Humans; Lung Neoplasms; Neuroendocrine Tumors; Octreotide; Peptides, Cyclic; Pneumonectomy; Small Cell Lung Carcinoma; Somatostatin | 2017 |
Metastatic carcinoid tumors and the malignant carcinoid syndrome.
Topics: Biomarkers, Tumor; Carcinoid Heart Disease; Carcinoid Tumor; Cisplatin; Combined Modality Therapy; Cyproheptadine; Echocardiography; Etoposide; Humans; Interferon Type I; Magnetic Resonance Imaging; Malignant Carcinoid Syndrome; Neoplasm Metastasis; Receptors, Somatostatin; Recombinant Proteins | 1994 |
16 other study(ies) available for etoposide and Carcinoid Tumor
Article | Year |
---|---|
Duodenal Obstruction Caused by the Long-term Recurrence of Appendiceal Goblet Cell Carcinoid.
Topics: Adult; Antineoplastic Agents; Appendectomy; Appendiceal Neoplasms; Carcinoid Tumor; Cisplatin; Colectomy; Duodenal Obstruction; Etoposide; Humans; Intestinal Neoplasms; Japan; Male; Neoplasm Recurrence, Local; Treatment Outcome | 2020 |
[Neuroendocrine tumors: analysis of 252 cases].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Cisplatin; Digestive System Neoplasms; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Palliative Care; Retrospective Studies; Sex Factors; Survival Rate; Young Adult | 2013 |
Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Platinum; Prognosis; Retrospective Studies; Survival Rate | 2014 |
[Case of thymic carcinoid associated with multiple endocrine neoplasia type I treated effectively with chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Cisplatin; Etoposide; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Thymus Neoplasms; Treatment Outcome | 2010 |
Ectopic ACTH syndrome due to thymic atypical carcinoid treated with combination chemotherapy of cisplatin and etoposide.
Topics: ACTH Syndrome, Ectopic; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Thymus Neoplasms; Tomography, X-Ray Computed | 2003 |
[A long-term survival case of hepatic metastasis of rectal carcinoid in which etoposide was effective].
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoid Tumor; Combined Modality Therapy; Etoposide; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Rectal Neoplasms; Survivors | 2004 |
Goblet cell carcinoid tumors (adenocarcinoid) of the appendix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Biomarkers, Tumor; Carcinoid Tumor; Cisplatin; Colectomy; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Fluorouracil; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Streptozocin | 2007 |
[Primary neuroendocrine carcinoma of the liver. From carcinoid tumor to small-cell hepatic carcinoma: case reports and review of the literature].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoid Tumor; Carcinoma; Carcinoma, Neuroendocrine; Cell Differentiation; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Rectal Neoplasms; Risk Factors; Treatment Outcome | 2008 |
Regression of choroidal metastases from a bronchial carcinoid tumor after chemotherapy with cisplatin and etoposide.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoid Tumor; Choroid Neoplasms; Cisplatin; Etoposide; Female; Humans; Remission Induction | 1994 |
Bronchial carcinoid tumor presenting as a thyroid nodule: an unusual clinical manifestation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoid Tumor; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Male; Octreotide; Streptozocin; Thyroid Neoplasms | 1996 |
[A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Remission Induction; Stomach Neoplasms; Vincristine | 1997 |
Mediastinal atypical carcinoid and neurofibromatosis type 1.
Topics: Carcinoid Tumor; Cell Nucleus; Cisplatin; Etoposide; Female; Humans; Mediastinal Neoplasms; Middle Aged; Mitochondria; Neurofibromatosis 1; Palliative Care; Radiography, Thoracic; Tomography, X-Ray Computed | 2000 |
High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Liver Neoplasms; Lymphatic Metastasis; Radionuclide Imaging; Receptors, Somatostatin; Somatostatin | 2000 |
Experience in treatment of metastatic pulmonary carcinoid tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Cisplatin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Somatostatin; Streptozocin; Survival Analysis | 2001 |
Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.
Topics: Adenoma, Islet Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Carcinoma; Cisplatin; Etoposide; Female; Gastrins; Glucagon; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Remission Induction; Survival Rate | 1991 |
Phase II trial of etoposide in APUD tumors.
Topics: Adenoma, Islet Cell; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoid Tumor; Drug Evaluation; Etoposide; Female; Gastrins; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Thyroid Neoplasms | 1987 |